238 related articles for article (PubMed ID: 17674979)
61. Adjuvant post-operative chemoradiotherapy in head and neck cancer: a standard of care?
Posner MR
Oncologist; 2005 Mar; 10(3):174-5. PubMed ID: 15793219
[No Abstract] [Full Text] [Related]
62. Chemoradiation for advanced head and neck cancer: potential for improving results to match those of current treatment modalities for early-stage tumors--long-term results of hyperfractionated chemoradiation with carbogen breathing and anemia correction with erythropoietin.
Villar A; Martinez JC; de Serdio JL
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1382-8. PubMed ID: 18037586
[TBL] [Abstract][Full Text] [Related]
63. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer.
Hall WH; Guiou M; Lee NY; Dublin A; Narayan S; Vijayakumar S; Purdy JA; Chen AM
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1362-7. PubMed ID: 18448267
[TBL] [Abstract][Full Text] [Related]
64. Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck.
Harrington KJ; El-Hariry IA; Holford CS; Lusinchi A; Nutting CM; Rosine D; Tanay M; Deutsch E; Matthews J; D'Ambrosio C; Turner SJ; Pandeshwara JS; Bourhis J
J Clin Oncol; 2009 Mar; 27(7):1100-7. PubMed ID: 19171712
[TBL] [Abstract][Full Text] [Related]
65. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
66. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
[TBL] [Abstract][Full Text] [Related]
67. Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer.
Suwiński R; Bańkowska-Woźniak M; Majewski W; Idasiak A; Maciejewski A; Ziółkowska E; Windorbska W; Składowski K; Miszczyk L; Maciejewski B
Radiother Oncol; 2008 May; 87(2):155-63. PubMed ID: 18342964
[TBL] [Abstract][Full Text] [Related]
68. Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.
Meade S; Sanghera P; McConkey C; Fowler J; Fountzilas G; Glaholm J; Hartley A
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):157-63. PubMed ID: 23332227
[TBL] [Abstract][Full Text] [Related]
69. Radiobiologic modeling of cytoprotection effects in radiotherapy.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):236-42. PubMed ID: 17448877
[TBL] [Abstract][Full Text] [Related]
70. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
Yom SS; Rosenthal DI
Nat Clin Pract Oncol; 2004 Nov; 1(1):14-5. PubMed ID: 16264790
[No Abstract] [Full Text] [Related]
71. Is one Gy equal to one Gy in chemo-radiotherapy or hormono-radiotherapy?
Corvò R; Berretta L; Andretta V
Rays; 2004; 29(3):287-9. PubMed ID: 15603300
[TBL] [Abstract][Full Text] [Related]
72. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship.
Kal HB; Veen RE
Strahlenther Onkol; 2005 Nov; 181(11):717-23. PubMed ID: 16254707
[TBL] [Abstract][Full Text] [Related]
73. Commentary: IMRT for head and neck cancer: many chapters left to write.
Allen AM; Tishler RB
Oncologist; 2007 May; 12(5):565-8. PubMed ID: 17522244
[No Abstract] [Full Text] [Related]
74. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
[No Abstract] [Full Text] [Related]
75. Is one Gy equal to one Gy after treatment interruptions?
Grillo-Ruggieri F; Mantello G
Rays; 2004; 29(3):275-8. PubMed ID: 15603297
[TBL] [Abstract][Full Text] [Related]
76. Biologic rationale of combined radiotherapy and chemotherapy.
Fu KK; Phillips TL
Hematol Oncol Clin North Am; 1991 Aug; 5(4):737-51. PubMed ID: 1890064
[TBL] [Abstract][Full Text] [Related]
77. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.
McAneney H; O'Rourke SF
Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369
[TBL] [Abstract][Full Text] [Related]
78. Head and neck cancer: advances in radiation treatment.
Eisbruch A
MedGenMed; 2002 May; 4(3):16. PubMed ID: 12466759
[No Abstract] [Full Text] [Related]
79. [Radiochemotherapy in head and neck neoplasms].
Munker R; Reitmeier M; Hartenstein R
Strahlenther Onkol; 2000 Nov; 176(11):537-8. PubMed ID: 11143531
[No Abstract] [Full Text] [Related]
80. Assessment of the radiation-equivalent of chemotherapy contributions in 1-phase radio-chemotherapy treatment of muscle-invasive bladder cancer.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):927-32. PubMed ID: 24462386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
